← All organizations

Repurposed Therapeutics, Inc.

For profitWebsite ↗

Also known as: Repurposed Therapeutics | Repurposed Therapeutics, Inc. | Repurposed Therapuetics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 23, 2022

Timeline

2010s

Jun 1, 2014
Repurposed Therapeutics, Inc.— Founded

Drugs by trial phase (2 distinct, 11 trials)

Phase 3 (1 own, 0 via acquisition)

scopolamine

Phase 2 (1 own, 0 via acquisition)

promethazine hydrochloride

Indications

Studied for

Recent trials (16)

NCT05548270Lead sponsorPhase 3Aug 23, 2022
NCT05886660Lead sponsorPhase 2Jan 21, 2022
NCT05852730Lead sponsorPhase 2Aug 10, 2021
NCT04947423Lead sponsorPhase 3Jun 14, 2021
NCT04184115Lead sponsorPhase 3Jun 9, 2019
NCT04184115Study directorPhase 3Jun 9, 2019
NCT03988530Lead sponsorPhase 3May 31, 2019
NCT03988530Study directorPhase 3May 31, 2019
NCT03986905Study directorPhase 3Apr 23, 2019
NCT03986905Lead sponsorPhase 3Apr 23, 2019
NCT04272255Study directorPhase 3Apr 22, 2019
NCT04272255Lead sponsorPhase 3Apr 22, 2019
NCT03874130Lead sponsorPhase 1Aug 1, 2018
NCT04219982Study directorPhase 2/Phase 3Jun 29, 2018
NCT04219982Lead sponsorPhase 2/Phase 3Jun 29, 2018

Details

Founded: Tampa, FL, US Jun 1, 2014
Last known activity: Aug 23, 2022

Notes

No evidence it is extant